Ionis Pharmaceuticals Correlations
IONS Stock | USD 33.19 1.84 5.87% |
The current 90-days correlation between Ionis Pharmaceuticals and Arrowhead Pharmaceuticals is 0.31 (i.e., Weak diversification). The correlation of Ionis Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Ionis Pharmaceuticals Correlation With Market
Modest diversification
The correlation between Ionis Pharmaceuticals and DJI is 0.27 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ionis Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Ionis |
Moving together with Ionis Stock
0.72 | ILMN | Illumina Sell-off Trend | PairCorr |
0.84 | INZY | Inozyme Pharma | PairCorr |
0.68 | KURA | Kura Oncology | PairCorr |
0.79 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.82 | ADTX | Aditxt Inc | PairCorr |
0.64 | STRO | Sutro Biopharma | PairCorr |
0.7 | TCRX | Tscan Therapeutics | PairCorr |
0.92 | TERN | Terns Pharmaceuticals | PairCorr |
0.87 | CRNX | Crinetics Pharmaceuticals Buyout Trend | PairCorr |
0.89 | CTMX | CytomX Therapeutics | PairCorr |
0.61 | EMBC | Embecta Corp | PairCorr |
0.62 | TLKMF | Telkom Indonesia Tbk | PairCorr |
Moving against Ionis Stock
0.73 | OPT | Opthea | PairCorr |
0.73 | GANX | Gain Therapeutics | PairCorr |
0.68 | PHGE | Biomx Inc | PairCorr |
0.61 | CUE | Cue Biopharma | PairCorr |
0.58 | LTRN | Lantern Pharma | PairCorr |
0.45 | PFE | Pfizer Inc | PairCorr |
0.41 | FENC | Fennec Pharmaceuticals | PairCorr |
0.56 | DBVT | DBV Technologies Earnings Call This Week | PairCorr |
0.4 | CPRX | Catalyst Pharmaceuticals | PairCorr |
0.34 | CGTX | Cognition Therapeutics | PairCorr |
0.83 | OBI | Ondine Biomedical | PairCorr |
0.76 | EC | Ecopetrol SA ADR Sell-off Trend | PairCorr |
0.75 | GPI | Group 1 Automotive | PairCorr |
0.74 | SSNLF | Samsung Electronics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Ionis Stock performing well and Ionis Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ionis Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ARWR | 3.13 | 0.19 | 0.05 | 0.09 | 3.68 | 5.87 | 35.58 | |||
BMRN | 1.25 | 0.18 | 0.10 | (1.14) | 1.70 | 3.13 | 10.00 | |||
INCY | 1.40 | 0.08 | 0.04 | 0.28 | 2.22 | 2.65 | 11.46 | |||
APLS | 2.31 | (0.06) | 0.00 | (0.07) | 0.00 | 4.63 | 27.73 | |||
VKTX | 3.21 | (0.77) | 0.00 | (1.37) | 0.00 | 4.30 | 24.65 | |||
ICPT | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
TERN | 2.99 | (0.56) | 0.00 | (0.52) | 0.00 | 5.17 | 26.61 | |||
AKRO | 4.26 | 1.18 | 0.36 | 1.19 | 2.68 | 4.90 | 103.16 | |||
RETA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Ionis Pharmaceuticals Corporate Management
Brett Monia | Sr. VP of Drug Discovery and Corporate Devel. | Profile | |
Patrick Esq | Chief VP | Profile | |
Eric Swayze | Executive Research | Profile | |
Hayley Soffer | Vice Communications | Profile |